comparemela.com

Card image cap


Vials of the Sputnik V vaccine.
|
AFP
India on Thursday registered 3,62,727 new coronavirus cases, taking the infection tally to 2,37,03,665 since the pandemic broke out in January last year. The country’s toll rose to 2,58,317 as it reported 4,120 deaths in the last day.
The Union health ministry on Thursday said Covid-19 vaccine Sputnik V will be available in Indian markets from next week. This is the third Covid-19 vaccine to receive emergency-use authorisation in India. Over 200 crore vaccine shots are likely to be available by December, NITI Aayog member Dr VK Paul said.
The gap between two doses of the Covishield vaccine can be increased to 12-16 weeks, the Centre said on Thursday. Currently, the recommended gap is six to eight weeks. However, no changes were made to the dosage regimen of Covaxin, whose recommended gap period is four to six weeks. Meanwhile, Bharat Biotech got approval for clinical trials of Covaxin on children aged 2-18.

Related Keywords

India , , Centre Vials Of The Sputnik , Health , Evening Headlines , Ndia Headlines , Ndia News , India Corona Updates , India Covid Updates , Coronavirus Vaccines , Sputnik Vaccines , Coronavirus Cases Today , Coronavirus , Covid 19 Vaccines , Sputnik V , இந்தியா , விட் தடுப்பு மருந்துகள் ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.